Filing Details
- Accession Number:
- 0001654954-17-000958
- Form Type:
- 13G Filing
- Publication Date:
- 2017-02-10 17:27:53
- Filed By:
- Honig Renee Hersey
- Company:
- Innoveren Scientific Inc. (NASDAQ:IVRN)
- Filing Date:
- 2017-02-10
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Renee Honig | 325,000 | 819,389 | 325,000 | 819,389 | 1,144,389 | 7.55% |
Filing
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
Amendment No. 1
To
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT
TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT
TO
RULE 13d-2(b)
MEDOVEX CORP.
(Name
of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title
of Class of Securities)
58504H101
(CUSIP
Number)
December 31, 2016
(Date
of Event Which Requires Filing of This Statement)
Check
the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ]
Rule 13d-1(b)
[ x]
Rule 13d-1(c)
[ ]
Rule 13d-1(d)
| CUSIP
No. 58504H101 |
| 1 | NAME
OF REPORTING PERSONS S.S.
OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY) Renee
Honig |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A
GROUP* (a)
☐
(b) ☐ |
| 3 | SEC
USE ONLY |
| 4 | CITIZENSHIP OR
PLACE OF ORGANIZATION United
States |
| NUMBER OF
SHARES | 5 | SOLE
VOTING POWER 325,000 |
| BENEFICIALLY OWNED
BY | 6 | SHARED
VOTING POWER 819,389(1) |
| EACH REPORTING | 7 | SOLE
DISPOSITIVE POWER 325,000 |
| PERSON
WITH | 8 | SHARED
DISPOSITIVE POWER 819,389(1) |
| 9 | AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,144,389(1) |
| 10 | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS) |
| 11 | PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW 9 7.55%
(Based on 15,032,107
shares outstanding as of November 16, 2016) |
| 12 | TYPE
OF REPORTING PERSON* IN |
(1)
Includes (i)
230,200 shares of common stock held by Renee Honig’s spouse,
Barry Honig, (ii) 95,952 shares of common stock underlying warrants
issued as part of a unit held by Barry Honig, (iii) 453,101 shares
of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry
Honig (“Roth 401K”), for which Barry Honig is trustee
and over which securities he holds voting and dispositive power,
(iv) 10,586 shares of common stock held by Marlin Capital
Investments, LLC (“Marlin”), for which Barry Honig is
the managing member and over which securities he holds voting and
dispositive power, and (iv) 29,550 shares of common stock
underlying warrants issued as part of a unit held by GRQ
Consultants, Inc. 401K (“401K”), for which Barry Honig
is trustee and over which securities he holds voting and
dispositive power. Excludes (i) 43,478 shares of common stock
underlying warrants held by Barry Honig, (ii) 95,000 shares of
common stock underlying warrants held by 401K, (iii) 68,508 shares
of common stock underlying warrants held by Roth 401K, and (iv)
75,000 shares of common stock underlying warrants held by Barry
& Renee Honig Charitable Foundation (the
“Foundation”), for which Barry Honig is trustee and
over which securities he holds voting and dispositive power. All of
these warrants contain a 4.99% beneficial ownership blocker, and as
such the Reporting Person’s beneficial ownership has been
limited accordingly.
| Item
(a). | Name of
Issuer: |
Medovex
Corp., a Nevada corporation (“Issuer”)
| Item
1(b). | Address
of Issuer's Principal Executive Offices: |
3279
Hardee Avenue
Atlanta,
Georgia 30341
| Item
2(a). | Name of
Person Filing. |
The
statement is filed on behalf of Renee Honig (the “Reporting
Person”).
| Item
2(b). | Address
of Principal Business Office or, if None, Residence. |
555
South Federal Highway #450, Boca Raton, FL 33432
| Item
2(c). | Citizenship. |
Renee
Honig is a citizen of the United States.
| Item
2(d). | Title
of Class of Securities. |
Common
Stock, par value $0.001.
| Item
2(e). | CUSIP
Number. |
58504H101
| Item
3. | Type of
Person. |
Not
applicable.
| Item
4. | Ownership. |
(a)
Amount beneficially owned: 1,144,389(1)
(b)
Percent of class: 7.55% (Based on 15,032,107 shares outstanding as of
November 16, 2016)
(c)
Number of shares as to which the person has:
(i)
Sole power to vote or to direct the vote: 325,000
(ii)
Shared power to vote or to direct the vote: 819,389
(1)
(iii)
Sole power to dispose or to direct the disposition of:
325,000
(iv)
Shared power to dispose or to direct the disposition
of: 819,389(1)
____________________________
(1)
Includes (i)
230,200 shares of common stock held by Renee Honig’s spouse,
Barry Honig, (ii) 95,952 shares of common stock underlying warrants
issued as part of a unit held by Barry Honig, (iii) 453,101 shares
of common stock held by Roth 401K, (iv) 10,586 shares of common
stock held by Marlin, and (iv) 29,550 shares of common stock
underlying warrants issued as part of a unit held by 401K. Excludes
(i) 43,478 shares of common stock underlying warrants held by Barry
Honig, (ii) 95,000 shares of common stock underlying warrants held
by 401K, (iii) 68,508 shares of common stock underlying warrants
held by Roth 401K, and (iv) 75,000 shares of common stock
underlying warrants held by the Foundation. All of these warrants
contain a 4.99% beneficial ownership blocker, and as such the
Reporting Person’s beneficial ownership has been limited
accordingly.
| Item
5. | Ownership of Five
Percent or Less of a Class. |
Not
applicable.
| Item
6. | Ownership of More
than Five Percent on Behalf of Another Person. |
Not
applicable.
| Item
7. | Identification
and Classification of the Subsidiary Which Acquired the Security
Being Reported by the Parent Holding Company. |
Not
applicable.
| Item
8. | Identification
and Classification of Members of the Group. |
Not
applicable.
| Item
9. | Notice
of Dissolution of Group. |
Not
applicable.
| Item
10. | Certifications. |
By
signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or
effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
| Date:
February 10, 2017 | By: | /s/ Renee
Honig | |
| | | Renee
Honig | |
| | | | |
| | | | |